Found: 34
Select item for more details and to access through your institution.
Emergence of a New Glucoregulatory Mechanism for Glycemic Control With Dapagliflozin/Exenatide Therapy in Type 2 Diabetes.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2024, v. 109, n. 1, p. 161, doi. 10.1210/clinem/dgad438
- By:
- Publication type:
- Article
Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production.
- Published in:
- Journal of Clinical Investigation, 2014, v. 124, n. 2, p. 509, doi. 10.1172/JCI70704
- By:
- Publication type:
- Article
Pioglitazona, una alternativa efectiva aún vigente para el control de la diabetes tipo 2.
- Published in:
- Medicina Interna de Mexico, 2021, v. 37, n. 5, p. 800, doi. 10.24245/mim.v37i5.4597
- By:
- Publication type:
- Article
Effect of Dapagliflozin With and Without Acipimox on Insulin Sensitivity and Insulin Secretion in T2DM Males.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Dapagliflozin lowers plasma glucose concentration and improves β-cell function.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Increase in endogenous glucose production with SGLT2 inhibition is attenuated in individuals who underwent kidney transplantation and bilateral native nephrectomy.
- Published in:
- Diabetologia, 2020, v. 63, n. 11, p. 2423, doi. 10.1007/s00125-020-05254-w
- By:
- Publication type:
- Article
Front Cover.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 10, p. C1, doi. 10.1111/dom.15964
- By:
- Publication type:
- Article
The potential role of finerenone in patients with type 1 diabetes and chronic kidney disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 10, p. 4135, doi. 10.1111/dom.15773
- By:
- Publication type:
- Article
Non‐steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease and type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 2, p. 417, doi. 10.1111/dom.15327
- By:
- Publication type:
- Article
Pioglitazone reduces epicardial fat and improves diastolic function in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 426, doi. 10.1111/dom.14885
- By:
- Publication type:
- Article
A new perspective on lowering CV risk from hypoglycaemia.
- Published in:
- European Heart Journal, 2020, v. 41, n. 2, p. 218, doi. 10.1093/eurheartj/ehz730
- By:
- Publication type:
- Article
Management of type 2 diabetes with oral semaglutide: Practical guidance for pharmacists.
- Published in:
- American Journal of Health-System Pharmacy, 2021, v. 78, n. 7, p. 556, doi. 10.1093/ajhp/zxaa413
- By:
- Publication type:
- Article
Prevalence and Heritability of Clusters for Diagnostic Components of Metabolic Syndrome: The Oman Family Study.
- Published in:
- Metabolic Syndrome & Related Disorders, 2008, v. 6, n. 2, p. 129, doi. 10.1089/met.2007.0039
- By:
- Publication type:
- Article
Cardioprotective Effects of Pioglitazone in Type 2 Diabetes.
- Published in:
- Diabetes Spectrum, 2021, v. 34, n. 3, p. 243, doi. 10.2337/ds20-0078
- By:
- Publication type:
- Article
Antihyperglycemic Algorithms for Type 2 Diabetes: Focus on Nonglycemic Outcomes.
- Published in:
- Diabetes Spectrum, 2021, v. 34, n. 3, p. 248, doi. 10.2337/ds20-0067
- By:
- Publication type:
- Article
Current Understanding of Sodium N-(8-[2-Hydroxylbenzoyl] Amino) Caprylate (SNAC) as an Absorption Enhancer: The Oral Semaglutide Experience.
- Published in:
- Clinical Diabetes, 2024, v. 42, n. 1, p. 74, doi. 10.2337/cd22-0118
- By:
- Publication type:
- Article
Do We Have to Increase Sensibility of Metabolic Syndrome Components? The Oman Family Study.
- Published in:
- Diabetes, 2007, v. 56, p. A266
- By:
- Publication type:
- Article
Empagliflozin Treatment Is Associated With Improved ß-Cell Function in Type 2 Diabetes Mellitus.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2018, v. 103, n. 4, p. 1402, doi. 10.1210/jc.2017-01838
- By:
- Publication type:
- Article
Empagliflozin Treatment Is Associated With Improved β-Cell Function in Type 2 Diabetes Mellitus.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Inhibition of renal glucose reabsorption as a novel treatment for diabetes patients.
- Published in:
- Brazilian Journal of Nephrology / Jornal Brasileiro de Nefrologia, 2014, v. 36, n. 1, p. 80, doi. 10.5935/0101-2800.20140014
- By:
- Publication type:
- Article
Dapagliflozin Impairs the Suppression of Endogenous Glucose Production in Type 2 Diabetes Following Oral Glucose.
- Published in:
- Diabetes Care, 2022, v. 45, n. 6, p. 1372, doi. 10.2337/dc21-1798
- By:
- Publication type:
- Article
Clinical Parameters, Fuel Oxidation, and Glucose Kinetics in Patients With Type 2 Diabetes Treated With Dapagliflozin Plus Saxagliptin.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Increase in Endogenous Glucose Production With SGLT2 Inhibition Is Unchanged by Renal Denervation and Correlates Strongly With the Increase in Urinary Glucose Excretion.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Pioglitazone Improves Left Ventricular Diastolic Function in Subjects With Diabetes.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Dapagliflozin Enhances Fat Oxidation and Ketone Production in Patients With Type 2 Diabetes.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Mechanisms of glucose lowering of dipeptidyl peptidase-4 inhibitor sitagliptin when used alone or with metformin in type 2 diabetes: a double-tracer study.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Mechanisms of Glucose Lowering of Dipeptidyl Peptidase-4 Inhibitor Sitagliptin When Used Alone or With Metformin in Type 2 Diabetes.
- Published in:
- Diabetes Care, 2013, v. 36, n. 9, p. 2756, doi. 10.2337/dc12-2072
- By:
- Publication type:
- Article
Nephropathy in Youth and Young Adults with Type 2 Diabetes.
- Published in:
- Current Diabetes Reports, 2014, v. 14, n. 2, p. 1, doi. 10.1007/s11892-013-0456-y
- By:
- Publication type:
- Article
Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2D and NGT Subjects.
- Published in:
- Diabetes, 2024, v. 73, n. 6, p. 896, doi. 10.2337/db23-0457
- By:
- Publication type:
- Article
Leptin Reduction as a Required Component for Weight Loss.
- Published in:
- Diabetes, 2024, v. 73, n. 2, p. 197, doi. 10.2337/db23-0571
- By:
- Publication type:
- Article
Effect of Mild Physiologic Hyperglycemia on Insulin Secretion, Insulin Clearance, and Insulin Sensitivity in Healthy Glucose-Tolerant Subjects.
- Published in:
- 2021
- By:
- Publication type:
- journal article
1851-P: Renal Denervation Attenuates Endogenous Glucose Production Increase with SGLT2 Inhibition in Patients with Renal Transplant Recipients and Impaired Fasting Glucose.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1851-P
- By:
- Publication type:
- Article
155-LB: The Increase in Endogenous Glucose Production with SGLT2 Inhibition Is Unchanged by Renal Denervation but Highly Correlates to Urinary Glucose Excretion.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-155-LB
- By:
- Publication type:
- Article
1935-P: Decoupling between ATP Utilization and Replenishment in Insulin Resistant Skeletal Muscle.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1935-P
- By:
- Publication type:
- Article